74 Biggest Movers From Friday

Gainers

• Genesco Inc. GCO rose 32.3% to close at $48.82 on Friday after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast.
• Big Lots, Inc. BIG gained 31.6% to close at $25.21 after the company reported upbeat results for its third quarter.
• KLX Energy Services Holdings, Inc. KLXE gained 30.7% to close at $5.53 after OPEC and OPEC+ agreed to further oil production cuts.
• Wellesley Bancorp, Inc. WEBK shares surged 30.3% to close at $42.10 on Friday. Cambridge Trust announced plans to acquire Wellesley Bank for $122 million.
• Cancer Genetics, Inc. CGIX gained 26.9% to close at $6.99.
• Sierra Oncology Inc SRRA surged 26.6% to close at $0.4850 after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $1.20 price target.
• DermTech, Inc. DMTK gained 26.1% to close at $11.90.
• SAExploration Holdings, Inc. SAEX surged 25% to close at $3.75.
• Kaleyra, Inc. KLR gained 22.8% to close at $8.55.
• Domo, Inc. DOMO rose 20% to close at $23.39 after the company reported Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
• Onconova Therapeutics Inc ONTX gained 19.8% to close at $0.35 after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.
• Epizyme, Inc. EPZM gained 19.1% to close at $18.22 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price action from $12 to $22 per share.
• Johnson Outdoors Inc. JOUT surged 19.1% to close at $78.17.
• Cerecor Inc. CERC gained 18.7% to close at $4.00.
• EZCORP, Inc. EZPW rose 18.4% to close at $6.19 following Q4 earnings.
• Montage Resources Corporation MR climbed 17.2% to close at $6.21. ScotiaBank upgraded Montage Resources from Sector Perform to Sector Outperform.
• Zumiez Inc. ZUMZ rose 16.1% to close at $35.47 after the company reported stronger-than-expected Q3 results and issued Q4 EPS guidance above analyst estimates.
• NF Energy Saving Corporation BIMI gained 16% to close at $3.85.
• Stoke Therapeutics, Inc. STOK jumped 15.8% to close at $28.98.
• Evolent Health, Inc. EVH shares climbed 15.7% to close at $7.73 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
• Lexicon Pharmaceuticals, Inc. LXRX rose 15.1% to close at $4.87 on continued momentum after the company reported the topline Phase 1 data for its LX9211.
• Signet Jewelers Limited SIG gained 15% to close at $20.58 on continued strength from Thursday's earnings report. Wells Fargo raised the price target to $16/share but said the company's core fundamental business remains 'pressured.'
• Tantech Holdings Ltd TANH gained 14.6% to close at $2.35.
• Rocket Pharmaceuticals, Inc. RCKT gained 13.5% to close at $22.36. Rocket Pharma reported that first patient has been treated in global registrational Phase 2 study of RP-L102 for fanconi anemia.
• BioLineRx Ltd. BLRX rose 13.2% to close at $2.31.
• Nabors Industries Ltd. NBR gained 12.9% to close at $2.36 after OPEC and OPEC+ agreed to further oil production cuts.
• LiveXLive Media, Inc. LIVX rose 12.8% to close at $2.30.
• National Beverage Corp. FIZZ climbed 12.1% to close at $54.06 following Q2 results.
• G1 Therapeutics, Inc. GTHX gained 11.5% to close at $22.90.
• Immunomedics, Inc. IMMU climbed 11.3% to close at $20.59 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
• Ulta Beauty, Inc. ULTA rose 11.1% to close at $262.20 after the company reported better-than-expected Q3 EPS results. The company also narrowed its FY19 EPS guidance above analyst estimates.
• Whiting Petroleum Corporation WLL surged 10.9% to close at $5.19 after OPEC and OPEC+ agreed to further oil production cuts.
• Alimera Sciences, Inc. ALIM gained 10.8% to close at $7.52.
• The Chemours Company CC climbed 10.8% to close at $16.68 on reports stating the House is said to be easing 'Forever chemical' wording.
• Prevail Therapeutics Inc. PRVL rose 10.8% to close at $15.54.
• Nine Energy Service, Inc. NINE surged 10.7% to close at $5.50.
• Calyxt, Inc. CLXT rose 10.2% to close at $5.40.
• The Michaels Companies, Inc. MIK gained 10% to close at $6.69.
• Kadmon Holdings, Inc. KDMN shares rose 10% to close at $4.50.
• Avadel Pharmaceuticals plc AVDL gained 9.4% to close at $6.30.
• Progyny, Inc. PGNY gained 9.4% to close at $30.49.
• PolarityTE, Inc. PTE surged 9.3% to close at $2.83.
• InMode Ltd. INMD gained 8.8% to close at $47.42 in sympathy with the overall market amid a rally in US equities following strong November jobs data.
• Cloudera, Inc. CLDR rose 8.7% to close at $10.88 after the company reported upbeat quarterly earnings.
• DocuSign, Inc. DOCU rose 8.7% to close at $75.57 after reporting better-than-expected Q3 earnings results.
• Clovis Oncology, Inc. CLVS gained 8.5% to close at $9.61 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
• Adverum Biotechnologies, Inc. ADVM gained 8.4% to close at $11.43 in sympathy with the overall market after a rally in US equities following strong November jobs data.
• Hovnanian Enterprises, Inc. HOV gained 7.9% to close at $26.94. Buckingham maintained Hovnanian with a Neutral and raised the price target from $24 to $27.
• Realogy Holdings Corp. RLGY climbed 7.3% to close at $10.46 after moving back above the $10 level. Not currently seeing any company-specific news.
• Sage Therapeutics, Inc. SAGE rose 7.1% to close at $64.46 after falling 59.67% on Thursday. SVB Leerink upgraded Sage Therapeutics from Underperform to Market Perform.
• Kiniksa Pharmaceuticals, Ltd. KNSA rose 6.4% to close at $10.61. Goldman Sachs upgraded Kiniksa Pharmaceuticals from Neutral to Buy and raised the price target from $16 to $18.
• Puma Biotechnology, Inc. PBYI rose 5.9% to close at $7.88. H.C. Wainwright initiated coverage on Puma Biotechnology with a Buy rating and a $15 price target.
• Harpoon Therapeutics, Inc. HARP climbed 5.6% to close at $18.93.

Check out these big penny stock gainers and losers

Losers

• Correvio Pharma Corp. CORV shares tumbled 39.8% to close at $1.30 on Friday.
• Axcella Health Inc. AXLA shares fell 20% to close at $3.59.
• Cortexyme, Inc. CRTX dropped 17.5% to close at $28.31.
• Liquid Media Group Ltd. YVR dipped 17.4% to close at $2.43.
• Kaleido BioSciences, Inc. KLDO shares declined 16.5% to close at $5.36.
• Cabaletta Bio, Inc. CABA dropped 16% to close at $10.21.
• Electromed, Inc. ELMD dipped 14.8% to close at $8.47.
• Yext, Inc. YEXT fell 14.1% to close at $14.26 after the company reported worse-than-expected Q3 EPS results and issued weak forecast.
• PagerDuty, Inc. PD shares fell 12.7% to close at $21.81 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 and FY20 EPS guidance below analyst estimates.
• Eloxx Pharmaceuticals, Inc. ELOX dropped 10.5% to close at $5.13.
• Intercept Pharmaceuticals, Inc. ICPT dipped 10.3% to close at $107.48. Intercept announced publication of results from the interim analysis of the Phase 3 REGENERATE study of OCA for the treatment of fibrosis due to NASH in The Lancet.
• Zoom Video Communications, Inc. ZM fell 10% to close at $62.74 after the company reported Q3 earnings results. The company also issued Q4 and FY20 guidance.
• China Automotive Systems, Inc. CAAS fell 9.7% to close at $3.52.
• Phathom Pharmaceuticals, Inc. PHAT shares dropped 9.4% to close at $24.24.
• IDT Corporation IDT fell 9.3% to close at $6.80 following Q1 results.
• Anavex Life Sciences Corp. AVXL dropped 8.9% to close at $2.65.
• IMAC Holdings, Inc. IMAC fell 8% to close at $1.84.
• Oyster Point Pharma, Inc. OYST shares fell 7.9% to close at $16.99.
• Guidewire Software Inc GWRE fell 7.2% to close at $110.77 after the company issued Q2 sales guidance below analyst estimates.
• Proteostasis Therapeutics, Inc. PTI declined 6.3% to close at $3.55.
• ASLAN Pharmaceuticals Limited ASLN fell 5.2% to close at $2.36 on continued downward momentum after the company priced a 5.2 million ADS offering at $2.50 per ADS.